Gain-of-function variants that increase GCK activity cluster at an allosteric activator site [25, 26] and cause hyperinsulinemic hypoglycemia (HH, MIM# 601820), which is characterized by increased insulin secretion even at low blood glucose levels [25, 27]. This evidence concerns the gene GCK and hyperinsulinemic hypoglycemia.